Navigation Links
Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other
Date:4/14/2011

NEW YORK, April 14, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Neurology Devices Market Outlook in China to 2017 – Neurostimulation Devices, Interventional Neurology and Other

http://www.reportlinker.com/p0479916/Neurology-Devices-Market-Outlook-in-China-to-2017-–-Neurostimulation-Devices-Interventional-Neurology-and-Other.html

Neurology Devices Market Outlook in China to 2017 – Neurostimulation Devices, Interventional Neurology and Other

Summary

GlobalData's new report, "Neurology Devices Market Outlook in China to 2017 – Neurostimulation Devices, Interventional Neurology and Other" provides key market data on the China Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts

Scope

- Market size and company share data for Neurology Devices market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the China Neurology Devicesmarket.

- Key players covered include Medtronic, Inc., Boston Scientific Corporation, B. Braun Melsungen AG, St. Jude Medical, Inc., DePuy, Inc., Covidien plc and others

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the China Neurology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 8

1.2 List of Figures 10

2 Introduction 12

2.1 What is This Report About? 12

3 Neurology Devices In China 13

3.1 Neurology Devices, Market Segmentation 13

3.2 Neurology Devices, China, Overall Revenue ($m), 2003-2017 14

3.3 Neurology Devices Market, China, Revenue Mix ($m), 2010 16

3.4 Neurology Devices Market, China, Category Contribution (%), 2010 17

3.5 Neurology Devices, China, Category Volume (Units), 2003-2017 24

3.6 Neurology Devices, China, Company Share (2009-2010) 29

4 CSF Management In China 31

4.1 CSF Management, Market Segmentation 31

4.2 CSF Management Market, China, Revenue Mix ($m), 2010 32

4.3 CSF Management Market, China, Segment Contribution (%), 2010 33

4.4 CSF Management Overall Revenue (2003-2017) 34

4.5 CSF Management Overall Volume (2003-2017) 38

4.6 CSF Management Average Price (2003-2017) 42

4.7 CSF Management Distribution Share (2009-2010) 43

4.8 CSF Management, China, Company Share (2009-2010) 44

5 Interventional Neurology In China 46

5.1 Interventional Neurology, Market Segmentation 46

5.2 Interventional Neurology, Market, China, Revenue Mix ($m), 2010 47

5.3 Interventional Neurology Market China, Segment Contribution (%), 2010 48

5.4 Interventional Neurology Overall Revenue (2003-2017) 49

5.4.1 Embolic Systems Revenue (2003-2017) 53

5.4.2 Navigational Systems Revenue (2003-2017) 56

5.5 Interventional Neurology Overall Volume (2003-2017) 60

5.5.1 Embolic Systems Volume (2003-2017) 64

5.5.2 Navigational Systems Volume (2003-2017) 68

5.6 Interventional Neurology Average Price (2003-2017) 72

5.7 Interventional Neurology Distribution Share (2009-2010) 73

5.8 Interventional Neurology, China, Company Share (2009-2010) 74

6 Neurological Diagnostic Equipment In China 76

6.1 Neurological Diagnostic Equipment, Market Segmentation 76

6.2 Neurological Diagnostic Equipment Market, China, Revenue Mix ($m), 2010 77

6.3 Neurological Diagnostic Equipment Market, China, Segment Contribution (%), 2010 78

6.4 Neurological Diagnostic Equipment Overall Revenue (2003-2017) 79

6.5 Neurological Diagnostic Equipment Overall Volume (2003-2017) 83

6.6 Neurological Diagnostic Equipment Average Price (2003-2017) 87

6.7 Neurological Diagnostic Equipment Distribution Share (2009-2010) 88

6.8 Neurological Diagnostic Equipment, China, Company Share (2009-2010) 89

7 Neurostimulation Devices In China 90

7.1 Neurostimulation Devices, Market Segmentation 90

7.2 Neurostimulation Devices, Market, China, Revenue Mix ($m), 2010 91

7.3 Neurostimulation Devices Market, China, Segment Contribution (%), 2010 92

7.4 Neurostimulation Devices Overall Revenue (2003-2017) 93

7.5 Neurostimulation Devices Overall Volume (2003-2017) 97

7.6 Neurostimulation Devices Average Price (2003-2017) 101

7.7 Neurostimulation Devices Distribution Share (2009-2010) 102

7.8 Neurostimulation Devices, China, Company Share (2009-2010) 103

8 Neurosurgical Products In China 104

8.1 Neurosurgical Products, Market Segmentation 104

8.2 Neurosurgical Products Market, China, Revenue Mix ($m), 2010 105

8.3 Neurosurgical Products Market, China, Segment Contribution (%), 2010 106

8.4 Neurosurgical Products Overall Revenue (2003-2017) 107

8.5 Neurosurgical Products Overall Volume (2003-2017) 111

8.6 Neurosurgical Products Average Price (2003-2017) 114

8.7 Neurosurgical Products Distribution Share (2009-2010) 115

8.8 Neurosurgical Products, China, Company Share (2009-2010) 116

9 Radiosurgery In China 117

9.1 Radiosurgery, Market Segmentation 117

9.2 Radiosurgery Overall Revenue (2003-2007) 118

9.3 Radiosurgery Overall Volume (2003-2007) 119

9.4 Radiosurgery Average Price (2003-2007) 120

10 Overview of Key Companies in China Neurology Devices Market 121

10.1 Medtronic, Inc. 121

10.1.1 Company Overview 121

10.1.2 Share in the China Neurology Devices Market 121

10.2 Boston Scientific Corporation 122

10.2.1 Company Overview 122

10.2.2 Share in the China Neurology Devices Market 122

10.3 B. Braun Melsungen AG 123

10.3.1 Company Overview 123

10.3.2 Share in the China Neurology Devices Market 123

10.4 St. Jude Medical, Inc. 124

10.4.1 Company Overview 124

10.4.2 Share in the China Neurology Devices Market 124

10.5 DePuy, Inc. 125

10.5.1 Company Overview 125

10.5.2 Share in the China Neurology Devices Market 125

10.6 Covidien plc 126

10.6.1 Company Overview 126

10.6.2 Share in the China Neurology Devices Market 126

10.7 Terumo Corporation 127

10.7.1 Company Overview 127

10.8 Integra LifeSciences Holdings Corporation 127

10.8.1 Company Overview 127

10.9 Micrus Endovascular Corporation 128

10.9.1 Company Overview 128

10.10 ev3 Inc. 128

10.10.1 Company Overview 128

10.11 CareFusion Corporation 129

10.11.1 Company Overview 129

10.12 Nihon Kohden Corporation 129

10.12.1 Company Overview 129

10.13 Elekta AB 130

10.13.1 Company Overview 130

10.14 Cadwell Laboratories, Inc. 130

10.14.1 Company Overview 130

10.15 Cyberonics, Inc. 130

10.15.1 Company Overview 130

10.16 Natus Medical Incorporated 131

10.16.1 Company Overview 131

10.17 Sophysa S.A. 131

10.17.1 Company Overview 131

10.18 KARL STORZ GmbH & Co. KG 131

10.18.1 Company Overview 131

11 Neurology Devices Market Pipeline Products 132

12 Financial Deals Landscape 136

12.1 Partnerships 136

12.1.1 Vycor Medical Enters Into Distribution Agreement with Devon Medical 136

13 Recent Developments 137

13.1 Strategy and Business Planning 137

13.1.1 Aug 08, 2010: Medtronic Opens Patient Care Center in Beijing, China 137

13.2 Product News 137

13.2.1 Apr 04, 2010: Study Identifies New Genetic Risk Factors For Brain Aneurysms 137

13.2.2 Mar 31, 2010: Genetic Defect In Schizophrenia Associates With Disruption In Brain Connection 138

13.2.3 Mar 31, 2010: New Preclinical Trial Gives Awareness Of Gene Mutation Causing Parkinson's Disease 140

14 Appendix 141

14.1 Definitions of Markets Covered in the Report 142

14.1.1 Neurology Devices 142

14.2 Research Methodology 145

14.3 Secondary Research 145

14.4 Primary Research 146

14.5 Models 146

14.6 Forecasts 147

14.7 Expert Panels 147

14.8 GlobalData Consulting 147

14.9 Currency Conversion 147

14.10 Contact Us 148

14.11 Disclaimer 148

1.1 List of Tables

Table 1: Neurology Devices, China, Overall Revenue ($m), 2003-2017 15

Table 2: Neurology Devices Market, China, Category Contribution (%), 2010 17

Table 3: Neurology Devices, China, Cross-Category Analysis, 2003-2017 19

Table 4: Neurology Devices, China, Overall Revenue ($m), Historic, 2003-2010 21

Table 5: Neurology Devices, China, Overall Revenue ($m), Forecast, 2010-2017 23

Table 6: Neurology Devices, China, Category Volume (Units), 2003-2017 24

Table 7: Neurology Devices, China, Category Volume (Units), Historic, 2003-2010 26

Table 8: Neurology Devices, China, Category Volume (Units), Forecast, 2010-2017 28

Table 9: Neurology Devices, China, Company Share by Revenue ($m), 2009-2010 30

Table 10: CSF Management Market, China, Segment Contribution (%), 2010 33

Table 11: CSF Management, China, Revenue ($m) by Segment, Historic, 2003-2010 35

Table 12: CSF Management, China, Revenue ($m) by Segment, Forecast, 2010-2017 37

Table 13: CSF Management, China, Volume (Units) by Segment, Historic, 2003-2010 39

Table 14: CSF Management, China, Volume (Units) by Segment, Forecast, 2010-2017 41

Table 15: CSF Management, China, Average Price ($), Historic, 2003-2010 42

Table 16: CSF Management, China, Average Price ($), Forecast, 2010-2017 42

Table 17: CSF Management, China, Distribution Share by Revenue ($m), 2009-2010 43

Table 18: CSF Management, China, Company Share by Revenue ($m), 2009-2010 45

Table 19: Interventional Neurology Market, China, Segment Contribution (%), 2010 48

Table 20: Interventional Neurology, China, Revenue ($m) by Segment, Historic, 2003-2010 50

Table 21: Interventional Neurology, China, Revenue ($m) by Segment, Forecast, 2010-2017 52

Table 22: Embolic Systems, China, Revenue ($m) by Sub-Segment, Historic, 2003-2010 53

Table 23: Embolic Systems, China, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 55

Table 24: Navigational Systems, China, Revenue ($m) by Sub-Segment, Historic, 2003-2010 57

Table 25: Navigational Systems, China, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 59

Table 26: Interventional Neurology, China, Volume (Units) by Segment, Historic, 2003-2010 61

Table 27: Interventional Neurology, China, Volume (Units) by Segment, Forecast, 2010-2017 63

Table 28: Embolic Systems, China, Volume (Units) by Sub-Segment, Historic, 2003-2010 65

Table 29: Embolic Systems, China, Volume (Units) by Sub-Segment, Forecast, 2010-2017 67

Table 30: Navigational Systems, China, Volume (Units) by Sub-Segment, Historic, 2003-2010 69

Table 31: Navigational Systems, China, Volume (Units) by Sub-Segment, Forecast, 2010-2017 71

Table 32: Interventional Neurology, China, Average Price ($), Historic, 2003-2010 72

Table 33: Interventional Neurology, China, Average Price ($), Forecast, 2010-2017 72

Table 34: Interventional Neurology, China, Distribution Share by Revenue ($m), 2009-2010 73

Table 35: Interventional Neurology, China, Company Share by Revenue ($m), 2009-2010 75

Table 36: Neurological Diagnostic Equipment Market, China, Segment Contribution (%), 2010 78

Table 37: Neurological Diagnostic Equipment, China, Revenue ($m) by Segment, Historic, 2003-2010 80

Table 38: Neurological Diagnostic Equipment, China, Revenue ($m) by Segment, Forecast, 2010-2017 82

Table 39: Neurological Diagnostic Equipment, China, Volume (Units) by Segment, Historic, 2003-2010 84

Table 40: Neurological Diagnostic Equipment, China, Volume (Units) by Segment, Forecast, 2010-2017 86

Table 41: Neurological Diagnostic Equipment, China, Average Price ($), Historic, 2003-2010 87

Table 42: Neurological Diagnostic Equipment, China, Average Price ($), Forecast, 2010-2017 87

Table 43: Neurological Diagnostic Equipment, China, Distribution Share by Revenue ($m), 2009-2010 88

Table 44: Neurological Diagnostic Equipment, China, Company Share by Revenue ($m), 2009-2010 89

Table 45: Neurostimulation Devices Market, China, Segment Contribution (%), 2010 92

Table 46: Neurostimulation Devices, China, Revenue ($m) by Segment, Historic, 2003-2010 94

Table 47: Neurostimulation Devices, China, Revenue ($m) by Segment, Forecast, 2010-2017 96

Table 48: Neurostimulation Devices, China, Volume (Units) by Segment, Historic, 2003-2010 98

Table 49: Neurostimulation Devices, China, Volume (Units) by Segment, Forecast, 2010-2017 100

Table 50: Neurostimulation Devices, China, Average Price ($), Historic, 2003-2010 101

Table 51: Neurostimulation Devices, China, Average Price ($), Forecast, 2010-2017 101

Table 52: Neurostimulation Devices, China, Distribution Share by Revenue ($m), 2009-2010 102

Table 53: Neurostimulation Devices, China, Company Share by Revenue ($m), 2009-2010 103

Table 54: Neurosurgical Products Market, China, Segment Contribution (%), 2010 106

Table 55: Neurosurgical Products, China, Revenue ($m) by Segment, Historic, 2003-2010 108

Table 56: Neurosurgical Products, China, Revenue ($m) by Segment, Forecast, 2010-2017 110

Table 57: Neurosurgical Products, China, Volume (Units) by Segment, Historic, 2003-2010 112

Table 58: Neurosurgical Products, China, Volume (Units) by Segment, Forecast, 2010-2017 113

Table 59: Neurosurgical Products, China, Average Price ($), Historic, 2003-2010 114

Table 60: Neurosurgical Products, China, Average Price ($), Forecast, 2010-2017 114

Table 61: Neurosurgical Products, China, Distribution Share by Revenue ($m), 2009-2010 115

Table 62: Neurosurgical Products, China, Company Share by Revenue ($m), 2009-2010 116

Table 63: Radiosurgery, China, Revenue ($m) by Segment, Historic, 2003-2007 118

Table 64: Radiosurgery, China, Volume (Units) by Segment, Historic, 2003-2007 119

Table 65: Radiosurgery, China, Average Price ($), Historic, 2003-2007 120

Table 66: Neurology Devices Market Pipeline Products 132

Table 67: Vycor Medical Enters Into Distribution Agreement With Devon Medical 136

Table 68: USD to Local Currency, China, Average Actual Rate 2003-2010 147

1.2 List of Figures

Figure 1: Neurology Devices, Market Segmentation 13

Figure 2: Neurology Devices, China, Overall Revenue ($m), 2003-2017 14

Figure 3: Neurology Devices Market, China, Revenue Mix ($m), 2010 16

Figure 4: Neurology Devices Market, China, Category Contribution (%), 2010 17

Figure 5: Neurology Devices, China, Cross-Category Analysis, 2003-2017 18

Figure 6: Neurology Devices, China, Overall Revenue ($m), Historic, 2003-2010 20

Figure 7: Neurology Devices, China, Overall Revenue ($m), Forecast, 2010-2017 22

Figure 8: Neurology Devices, China, Category Volume (Units), 2003-2017 24

Figure 9: Neurology Devices, China, Category Volume (Units), Historic, 2003-2010 25

Figure 10: Neurology Devices, China, Category Volume (Units), Forecast, 2010-2017 27

Figure 11: Neurology Devices, China, Company Share (%), 2010 29

Figure 12: CSF Management, Market Segmentation 31

Figure 13: CSF Management Market, China, Revenue Mix ($m), 2010 32

Figure 14: CSF Management Market, China, Segment Contribution (%), 2010 33

Figure 15: CSF Management, China, Revenue ($m) by Segment, Historic, 2003-2010 34

Figure 16: CSF Management, China, Revenue ($m) by Segment, Forecast, 2010-2017 36

Figure 17: CSF Management, China, Volume (Units) by Segment, Historic, 2003-2010 38

Figure 18: CSF Management, China, Volume (Units) by Segment, Forecast, 2010-2017 40

Figure 19: CSF Management, China, Company Share (%), 2010 44

Figure 20: Interventional Neurology, Market Segmentation 46

Figure 21: Interventional Neurology, Market, China, Revenue Mix ($m), 2010 47

Figure 22: Interventional Neurology, Market, China, Segment Contribution (%), 2010 48

Figure 23: Interventional Neurology, China, Revenue ($m) by Segment, Historic, 2003-2010 49

Figure 24: Interventional Neurology, China, Revenue ($m) by Segment, Forecast, 2010-2017 51

Figure 25: Embolic Systems, China, Revenue ($m) by Sub-Segment, Historic, 2003-2010 53

Figure 26: Embolic Systems, China, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 54

Figure 27: Navigational Systems, China, Revenue ($m) by Sub-Segment, Historic, 2003-2010 56

Figure 28: Navigational Systems, China, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 58

Figure 29: Interventional Neurology, China, Volume (Units) by Segment, Historic, 2003-2010 60

Figure 30: Interventional Neurology, China, Volume (Units) by Segment, Forecast, 2010-2017 62

Figure 31: Embolic Systems, China, Volume (Units) by Sub-Segment, Historic, 2003-2010 64

Figure 32: Embolic Systems, China, Volume (Units) by Sub-Segment, Forecast, 2010-2017 66

Figure 33: Navigational Systems, China, Volume (Units) by Sub-Segment, Historic, 2003-2010 68

Figure 34: Navigational Systems, China, Volume (Units) by Sub-Segment, Forecast, 2010-2017 70

Figure 35: Interventional Neurology, China, Company Share (%), 2010 74

Figure 36: Neurological Diagnostic Equipment, Market Segmentation 76

Figure 37: Neurological Diagnostic Equipment Market, China, Revenue Mix ($m), 2010 77

Figure 38: Neurological Diagnostic Equipment Market, China, Segment Contribution (%), 2010 78

Figure 39: Neurological Diagnostic Equipment, China, Revenue ($m) by Segment, Historic, 2003-2010 79

Figure 40: Neurological Diagnostic Equipment, China, Revenue ($m) by Segment, Forecast, 2010-2017 81

Figure 41: Neurological Diagnostic Equipment, China, Volume (Units) by Segment, Historic, 2003-2010 83

Figure 42: Neurological Diagnostic Equipment, China, Volume (Units) by Segment, Forecast, 2010-2017 85

Figure 43: Neurological Diagnostic Equipment, China, Company Share (%), 2010 89

Figure 44: Neurostimulation Devices, Market Segmentation 90

Figure 45: Neurostimulation Devices Market, China, Revenue Mix ($m), 2010 91

Figure 46: Neurostimulation Devices Market, China, Segment Contribution (%), 2010 92

Figure 47: Neurostimulation Devices, China, Revenue ($m) by Segment, Historic, 2003-2010 93

Figure 48: Neurostimulation Devices, China, Revenue ($m) by Segment, Forecast, 2010-2017 95

Figure 49: Neurostimulation Devices, China, Volume (Units) by Segment, Historic, 2003-2010 97

Figure 50: Neurostimulation Devices, China, Volume (Units) by Segment, Forecast, 2010-2017 99

Figure 51: Neurostimulation Devices, China, Company Share (%), 2010 103

Figure 52: Neurosurgical Products, Market Segmentation 104

Figure 53: Neurosurgical Products Market, China, Revenue Mix ($m), 2010 105

Figure 54: Neurosurgical Products Market, China, Segment Contribution (%), 2010 106

Figure 55: Neurosurgical Products, China, Revenue ($m) by Segment, Historic, 2003-2010 107

Figure 56: Neurosurgical Products, China, Revenue ($m) by Segment, Forecast, 2010-2017 109

Figure 57: Neurosurgical Products, China, Volume (Units) by Segment, Historic, 2003-2010 111

Figure 58: Neurosurgical Products, China, Volume (Units) by Segment, Forecast, 2010-2017 113

Figure 59: Neurosurgical Products, China, Company Share (%), 2010 116

Figure 60: Radiosurgery, Market Segmentation 117

Figure 61: Radiosurgery, China, Revenue ($m) by Segment, Historic, 2003-2007 118

Figure 62: Radiosurgery, China, Volume (Units) by Segment, Historic, 2003-2007 119

Figure 63: Medtronic, Inc., Company Share (%),China Neurology Devices Market, 2010 121

Figure 64: Boston Scientific Corporation, Company Share (%),China Neurology Devices Market, 2010 122

Figure 65: B. Braun Melsungen AG, Company Share (%),China Neurology Devices Market, 2010 123

Figure 66: St. Jude Medical, Inc., Company Share (%),China Neurology Devices Market, 2010 124

Figure 67: DePuy, Inc., Company Share (%),China Neurology Devices Market, 2010 125

Figure 68: Covidien plc, Company Share (%),China Neurology Devices Market, 2010 126Medtronic, Inc.

Boston Scientific Corporation

B. Braun Melsungen AG

St. Jude Medical, Inc.

DePuy, Inc.

Covidien plc

Terumo Corporation

Integra LifeSciences Holdings Corporation

Micrus Endovascular Corporation

ev3 Inc.

CareFusion Corporation

Nihon Kohden Corporation

Elekta AB

Cadwell Laboratories, Inc.

Cyberonics, Inc.

Natus Medical Incorporated

Sophysa S.A.

KARL STORZ GmbH & Co. KG

To order this report:

: Neurology Devices Market Outlook in China to 2017 – Neurostimulation Devices, Interventional Neurology and Other

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related biology technology :

1. Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
2. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
3. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
4. Reportlinker Adds Proteomics: Technologies and Global Markets Report
5. Reportlinker Adds Nanomedicine Report
6. Reportlinker Adds Small Molecule Kinase Inhibitors Report
7. Reportlinker Adds Nanoporous Materials Report
8. Reportlinker Adds Membrane Bioreactors Report
9. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
10. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
11. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 11, 2016 Non-profit Consortium Aims to ... to Support Research and Discovery --> ... an ambitious plan to sequence 100,000 individuals. It is intended ... at least 7 of North and East Asian countries. ... phase, the project will focus on creating phased reference genomes ...
(Date:2/11/2016)... 2016  Spectra BioPharma Selling Solutions (Spectra) is ... biopharma companies the experience, expertise, operational delivery and ... sales teams. Created in concert with industry leading ... strategic and tactical needs of its clients by ... both personal and non-personal promotion. ...
(Date:2/11/2016)...   BioInformant announces the February 2016 release ... Opportunities, Tools, and Technologies – Market Size, Segments, Trends, ... The first and only market ... BioInformant has more than a decade of historical information ... stem cell type. This powerful 175 page global strategic ...
(Date:2/10/2016)... 2016 Early-career researchers from ... , Uganda and Yemen ... and nutrition   Indonesia , Nepal ... and Yemen are being honored for their accomplishments ... also celebrated for mentoring young women scientists who are pursuing careers in ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016 This BCC ... bioinformatic market by reviewing the recent advances in ... that drive the field forward. Includes forecast through ... Identify the challenges and opportunities that exist in ... software solution developers, as well as IT and ...
(Date:2/2/2016)... , Feb. 2, 2016  Based on ... Frost & Sullivan recognizes US-based Intelligent Retinal Imaging ... & Sullivan Award for New Product Innovation. IRIS, ... North America , is poised ... rapidly growing diabetic retinopathy market. The IRIS technology ...
(Date:1/28/2016)... SYNA ), a leading developer of human interface solutions, today ... --> --> Net revenue ... to the comparable quarter last year to $470.5 million. Net income ... $0.93 per diluted share. --> ... 2016 grew 9 percent over the prior year period to $60.3 ...
Breaking Biology News(10 mins):